A citation-based method for searching scientific literature

Y Shen, C S Park, K Suppipat, T-A Mistretta, M Puppi, T M Horton, K Rabin, N S Gray, J P P Meijerink, H D Lacorazza. Leukemia 2017
Times Cited: 16







List of co-cited articles
91 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
Hanfeng Guan, Linka Xie, Frank Leithäuser, Lucia Flossbach, Peter Möller, Thomas Wirth, Alexey Ushmorov. Blood 2010
95
37

Krüppel-like factor 4 blocks tumor cell proliferation and promotes drug resistance in multiple myeloma.
Matthieu Schoenhals, Alboukadel Kassambara, Jean-Luc Veyrune, Jerome Moreaux, Hartmut Goldschmidt, Dirk Hose, Bernard Klein. Haematologica 2013
22
31

CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.
Katrin Faber, Lars Bullinger, Christine Ragu, Angela Garding, Daniel Mertens, Christina Miller, Daniela Martin, Daniel Walcher, Konstanze Döhner, Hartmut Döhner,[...]. J Clin Invest 2013
39
31

Krüppel-like factor 4 (KLF4): What we currently know.
Amr M Ghaleb, Vincent W Yang. Gene 2017
180
31


Kruppel-like factor 4 (KLF4) promotes the survival of natural killer cells and maintains the number of conventional dendritic cells in the spleen.
Chun Shik Park, Ping-Hsien Lee, Takeshi Yamada, Audrea Burns, Ye Shen, Monica Puppi, H Daniel Lacorazza. J Leukoc Biol 2012
22
25

Transcription factor ELF4 controls the proliferation and homing of CD8+ T cells via the Krüppel-like factors KLF4 and KLF2.
Takeshi Yamada, Chun Shik Park, Maksim Mamonkin, H Daniel Lacorazza. Nat Immunol 2009
82
25


Evolution of multiple cell clones over a 29-year period of a CLL patient.
Zhikun Zhao, Lynn Goldin, Shiping Liu, Liang Wu, Weiyin Zhou, Hong Lou, Qichao Yu, Shirley X Tsang, Miaomiao Jiang, Fuqiang Li,[...]. Nat Commun 2016
20
25


SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase.
B L Bennett, D T Sasaki, B W Murray, E C O'Leary, S T Sakata, W Xu, J C Leisten, A Motiwala, S Pierce, Y Satoh,[...]. Proc Natl Acad Sci U S A 2001
18

Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer.
Weidong Zhao, Irfan M Hisamuddin, Mandayam O Nandan, Brian A Babbin, Neil E Lamb, Vincent W Yang. Oncogene 2004
237
18

Role of the reprogramming factor KLF4 in blood formation.
Chun Shik Park, Ye Shen, Andrew Lewis, H Daniel Lacorazza. J Leukoc Biol 2016
18
18

The bottleneck of JNK signaling: molecular and functional characteristics of MKK4 and MKK7.
Wiebke Haeusgen, Thomas Herdegen, Vicki Waetzig. Eur J Cell Biol 2011
94
18

MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence.
Teiji Wada, Nicholas Joza, Hai-ying M Cheng, Takehiko Sasaki, Ivona Kozieradzki, Kurt Bachmaier, Toshiaki Katada, Martin Schreiber, Erwin F Wagner, Hiroshi Nishina,[...]. Nat Cell Biol 2004
119
18


HDAC1 and Klf4 interplay critically regulates human myeloid leukemia cell proliferation.
Y Huang, J Chen, C Lu, J Han, G Wang, C Song, S Zhu, C Wang, G Li, J Kang,[...]. Cell Death Dis 2014
35
18

Discovery of potent and selective covalent inhibitors of JNK.
Tinghu Zhang, Francisco Inesta-Vaquera, Mario Niepel, Jianming Zhang, Scott B Ficarro, Thomas Machleidt, Ting Xie, Jarrod A Marto, NamDoo Kim, Taebo Sim,[...]. Chem Biol 2012
200
18

MKK7 mediates miR-493-dependent suppression of liver metastasis of colon cancer cells.
Hiroaki Sakai, Ai Sato, Yuki Aihara, Yoshinori Ikarashi, Yutaka Midorikawa, Michael Kracht, Hitoshi Nakagama, Koji Okamoto. Cancer Sci 2014
35
18

Krüppel-like factors in cancer.
Marie-Pier Tetreault, Yizeng Yang, Jonathan P Katz. Nat Rev Cancer 2013
205
18

Expression of KLF4 is a predictive marker for survival in pediatric Burkitt lymphoma.
Alberto Valencia-Hipόlito, Miriam Hernández-Atenógenes, Gabriel G Vega, Altagracia Maldonado-Valenzuela, Guillermo Ramon, Héctor Mayani, Yolanda Peña Alonso, Otoniel Martinez-Maza, Alfonso Méndez-Tenorio, Sara Huerta-Yepez,[...]. Leuk Lymphoma 2014
15
20

The stress kinase MKK7 couples oncogenic stress to p53 stability and tumor suppression.
Daniel Schramek, Athanassios Kotsinas, Arabella Meixner, Teiji Wada, Ulrich Elling, J Andrew Pospisilik, G Gregory Neely, Ralf-Harun Zwick, Verena Sigl, Guido Forni,[...]. Nat Genet 2011
76
18

limma powers differential expression analyses for RNA-sequencing and microarray studies.
Matthew E Ritchie, Belinda Phipson, Di Wu, Yifang Hu, Charity W Law, Wei Shi, Gordon K Smyth. Nucleic Acids Res 2015
18

Acute lymphoblastic leukaemia.
Ching-Hon Pui, Leslie L Robison, A Thomas Look. Lancet 2008
943
18

Inactivation of the p53-KLF4-CEBPA Axis in Acute Myeloid Leukemia.
Katja Seipel, Miguel Teixera Marques, Marie-Ange Bozzini, Christina Meinken, Beatrice U Mueller, Thomas Pabst. Clin Cancer Res 2016
30
18

Novel tumor-suppressor function of KLF4 in pediatric T-cell acute lymphoblastic leukemia.
Ye Shen, Taylor J Chen, H Daniel Lacorazza. Exp Hematol 2017
12
25

KLF4, p21 and context-dependent opposing forces in cancer.
Benjamin D Rowland, Daniel S Peeper. Nat Rev Cancer 2006
399
18

A KLF4-DYRK2-mediated pathway regulating self-renewal in CML stem cells.
Chun Shik Park, Andrew H Lewis, Taylor J Chen, Cory S Bridges, Ye Shen, Koramit Suppipat, Monica Puppi, Julie A Tomolonis, Paul D Pang, Toni-Ann Mistretta,[...]. Blood 2019
20
18

Concise Review: Regulation of Self-Renewal in Normal and Malignant Hematopoietic Stem Cells by Krüppel-Like Factor 4.
Chun S Park, Andrew Lewis, Taylor Chen, Daniel Lacorazza. Stem Cells Transl Med 2019
17
18


Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation.
Lijian Hui, Kurt Zatloukal, Harald Scheuch, Ewa Stepniak, Erwin F Wagner. J Clin Invest 2008
231
12

Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma.
Yukiko Nakahara, Paul A Northcott, Meihua Li, Paul N Kongkham, Christian Smith, Hai Yan, Sidney Croul, Young-Shin Ra, Charles Eberhart, Annie Huang,[...]. Neoplasia 2010
55
12

Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes.
Wei Li, Zhiwu Jiang, Tianzhong Li, Xinru Wei, Yi Zheng, Donghai Wu, Lijian Yang, Shaohua Chen, Bing Xu, Mei Zhong,[...]. Mol Cancer 2015
18
12

Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.
Richard H Ko, Lingyun Ji, Phillip Barnette, Bruce Bostrom, Raymond Hutchinson, Elizabeth Raetz, Nita L Seibel, Clare J Twist, Elena Eckroth, Richard Sposto,[...]. J Clin Oncol 2010
174
12

The stress kinase mitogen-activated protein kinase kinase (MKK)7 is a negative regulator of antigen receptor and growth factor receptor-induced proliferation in hematopoietic cells.
T Sasaki, T Wada, H Kishimoto, J Irie-Sasaki, G Matsumoto, T Goto, Z Yao, A Wakeham, T W Mak, A Suzuki,[...]. J Exp Med 2001
47
12


Selective interaction of JNK protein kinase isoforms with transcription factors.
S Gupta, T Barrett, A J Whitmarsh, J Cavanagh, H K Sluss, B Dérijard, R J Davis. EMBO J 1996
12

Deregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets.
Valerie A Morris, Carrie L Cummings, Brendan Korb, Sean Boaglio, Vivian G Oehler. Mol Cell Biol 2015
24
12

Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway.
C Tournier, P Hess, D D Yang, J Xu, T K Turner, A Nimnual, D Bar-Sagi, S N Jones, R A Flavell, R J Davis. Science 2000
12


Critical roles of NOTCH1 in acute T-cell lymphoblastic leukemia.
Hudan Liu, Mark Y Chiang, Warren S Pear. Int J Hematol 2011
18
12

Development of JNK2-selective peptide inhibitors that inhibit breast cancer cell migration.
Tamer S Kaoud, Shreya Mitra, Sunbae Lee, Juliana Taliaferro, Michael Cantrell, Klaus D Linse, Carla L Van Den Berg, Kevin N Dalby. ACS Chem Biol 2011
32
12

The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.
Bryan King, Thomas Trimarchi, Linsey Reavie, Luyao Xu, Jasper Mullenders, Panagiotis Ntziachristos, Beatriz Aranda-Orgilles, Arianne Perez-Garcia, Junwei Shi, Christopher Vakoc,[...]. Cell 2013
205
12

Krüppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by inhibition of NOTCH signaling.
Katharina Filarsky, Angela Garding, Natalia Becker, Christine Wolf, Manuela Zucknick, Rainer Claus, Dieter Weichenhan, Christoph Plass, Hartmut Döhner, Stephan Stilgenbauer,[...]. Haematologica 2016
16
12


Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.
Andrew P Weng, Adolfo A Ferrando, Woojoong Lee, John P Morris, Lewis B Silverman, Cheryll Sanchez-Irizarry, Stephen C Blacklow, A Thomas Look, Jon C Aster. Science 2004
12

MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines.
C Tournier, C Dong, T K Turner, S N Jones, R A Flavell, R J Davis. Genes Dev 2001
270
12

Targeting JNK for therapeutic benefit: from junk to gold?
Anthony M Manning, Roger J Davis. Nat Rev Drug Discov 2003
480
12


VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages.
Pantelis Georgiades, Sarah Ogilvy, Hélène Duval, Diana R Licence, D Stephen Charnock-Jones, Stephen K Smith, Cristin G Print. Genesis 2002
140
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.